Table Of Contents
1. Market Context & Strategic Relevance
1.1 Opening Context (Why the market matters)
1.1.1 Why This Market Is Gaining Strategic Attention
1.1.2 Business Decisions This Report Supports
1.2 Scope
1.3 Research & Methodology
2. Executive Summary
2.1 Market Snapshot
2.2 Market Absolute $ Opportunity Assessment & Y-o-Y Analysis, 2022–2035
2.3 Market Size & Forecast, By Segmentation, 2022–2035
2.3.1 Market Size By Product
2.3.2 Market Size By Test Type
2.3.3 Market Size By Application
2.3.4 Market Size By End User
2.4 Market Share & Bps Analysis By Region, 2025
2.5 Industry Growth Scenarios – Conservative, Likely & Optimistic
2.6 Industry CxO’s Perspective
3. Market Overview
3.1 Market Dynamics
3.1.1 Drivers
3.1.2 Restraints
3.1.3 Opportunities
3.1.4 Key Market Trends
3.2 Industry PESTLE Analysis
3.3 Key Industry Forces (Porter’s) Impacting Market Growth
3.4 Industry Supply Chain Analysis
3.4.1 Reagent, Strip Chemistry, Optics & Electronics Component Suppliers
3.4.2 Urinalysis Strip, Reagent & Analyzer Manufacturers
3.4.3 Medical Distributors, Pharmacies & Online Retail Channels
3.4.4 Hospitals, Diagnostic Laboratories & Home Care Users
3.5 Industry Life Cycle Assessment
4. Statistical Insights & Trends Reporting
4.1 Disease Burden & Testing Demand Indicators
4.1.1 Urinary Tract Infection Incidence by Age & Gender
4.1.2 Diabetes & Chronic Kidney Disease Screening Rates
4.1.3 Catheter-Associated Infection Testing Volumes
4.1.4 Pregnancy & Fertility Test Utilization
4.2 Laboratory Workflow & Testing Metrics
4.2.1 Dipstick vs. Automated Analyzer Test Share
4.2.2 Manual Microscopy vs. Automated Sediment Analysis
4.2.3 Emergency & Primary Care Urine Test Volumes
4.2.4 Turnaround Time & Reflex Culture Ordering Rates
4.3 Home Testing & Digital Adoption
4.3.1 Smartphone-Read Strip Adoption
4.3.2 Over-the-Counter Urinary Infection Test Sales
4.3.3 Telehealth-Prescribed Home Kit Usage
4.3.4 Digital Result Sharing with Clinicians
4.4 Technology & Automation Trends
4.4.1 Flow Cytometry & Digital Imaging in Sediment Analysis
4.4.2 AI Classification of Abnormal Samples
4.4.3 Integrated Analyzer & Laboratory Information System Connectivity
4.4.4 Albumin & Kidney Marker Test Innovation
4.5 Regulatory, Quality & Reimbursement Environment
4.5.1 Clearances for Non-Professional Use Urinalysis Products
4.5.2 Quality & Proficiency Testing Standards
4.5.3 Reimbursement for Routine Urine Testing
4.5.4 Antibiotic Stewardship Guidelines Linked to Urine Testing
5. Urinalysis Market Segmental Analysis & Forecast, By Product, 2022–2035, Value (USD Billion)
5.1 Introduction
5.2 Consumables
5.2.1 Key Trends
5.2.2 Market Size & Forecast, 2022–2035
5.3 Instruments
6. Urinalysis Market Segmental Analysis & Forecast, By Test Type, 2022–2035, Value (USD Billion)
6.1 Introduction
6.2 Biochemical
6.2.1 Key Trends
6.2.2 Market Size & Forecast, 2022–2035
6.3 Sediment
6.4 Others
7. Urinalysis Market Segmental Analysis & Forecast, By Application, 2022–2035, Value (USD Billion)
7.1 Introduction
7.2 Urinary Tract Infection
7.2.1 Key Trends
7.2.2 Market Size & Forecast, 2022–2035
7.3 Diabetes
7.4 Kidney Disease
7.5 Pregnancy and Fertility
7.6 Others
8. Urinalysis Market Segmental Analysis & Forecast, By End User, 2022–2035, Value (USD Billion)
8.1 Introduction
8.2 Hospitals
8.2.1 Key Trends
8.2.2 Market Size & Forecast, 2022–2035
8.3 Diagnostic Laboratories
8.4 Home Care
8.5 Others
9. Urinalysis Market Segmental Analysis & Forecast By Region, 2022–2035, Value (USD Billion)
9.1 Introduction
9.2 North America
9.2.1 Key Trends
9.2.2 Urinalysis Market Size & Forecast, By Product, 2022–2035
9.2.3 Urinalysis Market Size & Forecast, By Test Type, 2022–2035
9.2.4 Urinalysis Market Size & Forecast, By Application, 2022–2035
9.2.5 Urinalysis Market Size & Forecast, By End User, 2022–2035
9.2.6 Urinalysis Market Size & Forecast, By Country, 2022–2035
9.2.6.1 USA
9.2.6.2 Canada
9.3 Europe
9.3.1 Key Trends
9.3.2 Urinalysis Market Size & Forecast, By Product, 2022–2035
9.3.3 Urinalysis Market Size & Forecast, By Test Type, 2022–2035
9.3.4 Urinalysis Market Size & Forecast, By Application, 2022–2035
9.3.5 Urinalysis Market Size & Forecast, By End User, 2022–2035
9.3.6 Urinalysis Market Size & Forecast, By Country, 2022–2035
9.3.6.1 Germany
9.3.6.2 UK
9.3.6.3 France
9.3.6.4 Italy
9.3.6.5 Spain
9.3.6.6 Russia
9.3.6.7 Poland
9.3.6.8 Rest of Europe
9.4 Asia-Pacific
9.4.1 Key Trends
9.4.2 Urinalysis Market Size & Forecast, By Product, 2022–2035
9.4.3 Urinalysis Market Size & Forecast, By Test Type, 2022–2035
9.4.4 Urinalysis Market Size & Forecast, By Application, 2022–2035
9.4.5 Urinalysis Market Size & Forecast, By End User, 2022–2035
9.4.6 Urinalysis Market Size & Forecast, By Country, 2022–2035
9.4.6.1 China
9.4.6.2 India
9.4.6.3 Japan
9.4.6.4 South Korea
9.4.6.5 Australia
9.4.6.6 ASEAN Countries
9.4.6.7 Rest of Asia-Pacific
9.5 Latin America
9.5.1 Key Trends
9.5.2 Urinalysis Market Size & Forecast, By Product, 2022–2035
9.5.3 Urinalysis Market Size & Forecast, By Test Type, 2022–2035
9.5.4 Urinalysis Market Size & Forecast, By Application, 2022–2035
9.5.5 Urinalysis Market Size & Forecast, By End User, 2022–2035
9.5.6 Urinalysis Market Size & Forecast, By Country, 2022–2035
9.5.6.1 Brazil
9.5.6.2 Argentina
9.5.6.3 Mexico
9.5.6.4 Colombia
9.5.6.5 Rest of Latin America
9.6 Middle East & Africa
9.6.1 Key Trends
9.6.2 Urinalysis Market Size & Forecast, By Product, 2022–2035
9.6.3 Urinalysis Market Size & Forecast, By Test Type, 2022–2035
9.6.4 Urinalysis Market Size & Forecast, By Application, 2022–2035
9.6.5 Urinalysis Market Size & Forecast, By End User, 2022–2035
9.6.6 Urinalysis Market Size & Forecast, By Country, 2022–2035
9.6.6.1 UAE
9.6.6.2 Saudi Arabia
9.6.6.3 Qatar
9.6.6.4 South Africa
9.6.6.5 Rest of Middle East & Africa
10. Competitive Landscape
10.1 Key Players' Positioning
10.2 Competitive Developments
10.2.1 Year-Wise Strategies & Development, 2022–2026
10.3 Market Share Analysis, 2025
10.4 Product/Service & Application Benchmarking
10.4.1 Product/Service Specifications & Features By Key Players
10.4.2 Product/Service Heatmap By Key Players
10.4.3 Application Heatmap By Key Players
10.5 Industry Start-Up & Innovation Landscape
10.6 Key Company Profiles
10.6.1 Siemens Healthineers AG
10.6.1.1 Company Overview & Snapshot
10.6.1.2 Product/Service Portfolio
10.6.1.3 Key Company Financials
10.6.1.4 Geographical Presence
10.6.1.5 SWOT Analysis
10.6.2 F. Hoffmann-La Roche Ltd
10.6.3 Sysmex Corporation
10.6.4 Beckman Coulter (Danaher Corporation)
10.6.5 ARKRAY, Inc.
10.6.6 ACON Laboratories, Inc.
10.6.7 Erba Mannheim
10.6.8 Analyticon Biotechnologies AG
10.6.9 Teco Diagnostics
10.6.10 Healthy.io
10.6.11 DIRUI Industrial Co., Ltd.
10.6.12 Sciteck Diagnostics
10.6.13 Hangzhou AllTest Biotech Co., Ltd.
10.6.14 Nova Biomedical
10.6.15 Biomerica, Inc.
10.6.16 Shenzhen Mindray Bio-Medical Electronics
10.6.17 URIT Medical Electronic Co., Ltd.
10.6.18 77 Elektronika Kft.
10.6.19 Clarity Diagnostics
10.6.20 Cardinal Health, Inc.
11. Analyst Recommendations
11.1 SNS Insider Opportunity Map
11.2 Industry Low-Hanging Fruit Assessment
11.3 Market Entry & Growth Strategy
11.4 Analyst Viewpoint & Suggestions On Market Growth
12. Assumptions
13. Disclaimer
14. Appendix
14.1 List Of Tables
14.2 List Of Figures
Frequently Asked Questions
Key players include Siemens Healthineers, Roche, Sysmex, Beckman Coulter, ARKRAY, ACON Laboratories, Erba Mannheim, Analyticon, Teco Diagnostics, Healthy.io, DIRUI, Sciteck, Hangzhou AllTest, Nova Biomedical, Biomerica, Mindray, URIT, 77 Elektronika, Clarity Diagnostics and Cardinal Health.
Key opportunities include over-the-counter and smartphone-read home tests, digital microscopy with AI classification, point-of-care albumin testing and fast-growing Asia Pacific demand.
Rising prevalence of chronic kidney disease, diabetes and urinary tract infections, together with decentralized testing, is the main growth factor.
By Product, the Consumables segment dominated the market in 2025 with an estimated 69.88% share, supported by recurring strip and reagent use.
North America dominated the market with a share of 37.35% in 2025, driven by high chronic disease prevalence and advanced laboratory networks.